Age (years) | 54 (11) |
Sex | |
Female | 15.6% |
Male | 84.4% |
Employment | |
Employed | 33.5% |
Unemployed/retired | 66.5% |
Diagnosis | |
Coronary artery disease | 25.4% |
Dilated cardiomyopathy | 57.6% |
Dilated cardiomyopathy with concomitant coronary artery disease | 10.7% |
Other | 6.3% |
Duration of CHF (years) | 4.7 (5.3) |
NYHA functional class | |
Class I | 11.8% |
Class II | 47.8% |
Class III | 40.4% |
Peak oxygen uptake (ml/kg/min) | 15.1 (5.1) |
Six minute walk test (m) | 470 (100) |
LVEF (%) | 22 (10) |
Drug treatment | |
ACE inhibitors | 96% |
Diuretics | 86% |
β Blockers | 38% |
Digitalis glycosides | 69% |
Anticoagulants | 75% |